Acuitas Investments’s LeonaBio Inc LONA Stock Holding History

Acuitas Investments’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,960	Closed	-$302K	–	119
2023 Q3	$302K	Buy	+14,960	New	+$383K	0.18%	102

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Acuitas Investments's LONA Position: Q4 2023 in Review

Acuitas Investments sold out of LeonaBio Inc (LONA) in Q4 2023, closing a stake of 14,960 shares — an estimated $302K sold.

Acuitas Investments first reported a position in LONA in Q3 2023 and held it in 1 quarter. The position peaked at $302K in Q3 2023. 65 funds tracked by Wall St. Rank hold LONA as of Q4 2023.

Acuitas Investments reported no remaining LeonaBio Inc position as of Q4 2023 after selling out during the quarter.
Acuitas Investments sold 14,960 LeonaBio Inc shares in Q4 2023, an estimated $302K.
Acuitas Investments first reported a position in LeonaBio Inc in Q3 2023 and held it in 1 quarter.
Acuitas Investments's LeonaBio Inc position peaked at $302K in Q3 2023.
65 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2023.

Based on Acuitas Investments's 13F filing for Q4 2023, filed 2 Feb 2024.